Rx ACCESS Act

This bill amends title 10 of the United States Code to improve access to certain medications under the TRICARE program for military beneficiaries. It allows beneficiaries to choose how they receive non-generic maintenance medications starting October 1, 2026, sets new reimbursement standards for retail pharmacies, prohibits certain fees by pharmacy benefit managers, and requires audits and a report.

Sec. 2, Improvements relating to access, fairness, and transparency under TRICARE pharmacy benefits program: This section has three parts. First, it amends the law so that starting October 1, 2026, eligible beneficiaries can choose to get non-generic maintenance medications through any allowed means, such as retail pharmacies. Second, it adds new standards for pharmacy benefit manager contracts: reimbursement to retail pharmacies must be at least the actual acquisition cost or a proxy based on the national average drug acquisition cost index, plus a professional dispensing fee equal to the state's Medicaid fee. The contractor cannot impose any fees on retail pharmacies, including point-of-sale or retroactive fees. Third, it requires the Comptroller General to audit reimbursement data and the adequacy of the retail pharmacy network at least annually, and submit results to Congress. The Secretary of Defense must ensure contractors provide needed information.

Sec. 3, Report: Within 90 days of enactment, the Secretary of Defense must submit a plan to Congress for implementing this section.